Stay updated on Expanded Access of Lifileucel in Melanoma: Clinical Trial

Sign up to get notified when there's something new on the Expanded Access of Lifileucel in Melanoma: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Expanded Access of Lifileucel in Melanoma: Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T13:55:54.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has undergone significant changes, including the removal of detailed information about the Expanded Access Program for AMTAGVI and its eligibility criteria, while introducing references to unresectable melanoma and a new version revision.
    Difference
    18%
    Check dated 2025-04-16T02:04:54.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-08T23:37:18.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The webpage has added several new hospital locations across various states, including California, Colorado, Connecticut, Illinois, and Iowa, while also updating the available date from February 2025 to March 2025.
    Difference
    4%
    Check dated 2025-04-01T18:30:15.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page has been updated to reflect an increase in study locations from 11 to 14, with specific new locations added in Arizona, Ohio, and Washington, including details about the institutions available at each site.
    Difference
    6%
    Check dated 2025-03-03T22:19:54.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The webpage now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    2%
    Check dated 2025-02-10T09:43:47.000Z thumbnail image

Stay in the know with updates to Expanded Access of Lifileucel in Melanoma: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Expanded Access of Lifileucel in Melanoma: Clinical Trial page.